Ophthalmology Time 2009 Media Kit
University of Arkansas for Medical Sciences receives $2.2 million grant to study efferocytosis in retinopathy
Latest advances in X-linked retinitis pigmentosa: Optimizing diagnosis and developments in gene therapy
AAO 2024 to “elevate” in Windy City
Advancing the optimal diagnosis & treatment of thyroid eye disease
EyeCon 2024: The path to leadership
4DMT presents data from phase 1/2 PRISM clinical trial and outlines 4FRONT phase 3 study